Articles tagged with "Biotech"
Sort by
Aston £18 mill bid to lead on science and tech
January 8, 2024
Aston University is investing £18 million in doctoral research funding to realise its aim of being a university leader in science, technology and enterprise.
Azenta’s Oxford genomics lab to open in March
December 21, 2023
Azenta Life Sciences has selected Oxford as the location for its state of the art genomics lab opening in early 2024.
AI responsibility remains in our hands, warns Ri Christmas Lecturer
December 18, 2023
Artificial intelligence is a powerful tool for better decision making but the ‘ethical buck’ stops with us, warns leading AI expert and Royal Institution Christmas lecturer, Professor Mike Wooldridge.
Turning down the heat
December 4, 2023
Selecting the right cold storage for academic laboratories is a challenge, acknowledges Rob Fowler, who explains how the University of Sussex has transformed its cold storage capabilities with an economic...
Flower power inspires drug cell breakthrough
December 4, 2023
Bath university scientists have borrowed from nature to develop more stable versions of proteins and peptides for more effective pharmaceutical treatments.
First phase of Oxford’s new 1 million sq. ft lab district begins
November 27, 2023
Laing O’Rourke will begin the initial phase of Oxford North’s £700 million new innovation district, with the aim of completing by the second quarter of 2025.
Autumn Statement: Chancellor confirms investment for growth via science
November 22, 2023
Chancellor Jeremy Hunt today confirmed the expected raft of commitments to boost the UK economy with significant support for science sectors.
BHF and UK DRI to create vascular dementia research centre
November 19, 2023
The British Heart Foundation (BHF) and the UK Dementia Research Institute (UK DRI) will establish the UK’s first research centre dedicated to finding new treatments for vascular dementia.
Bioinformatician’s data protection work wins 2023 Einstein Prize
November 19, 2023
One of the world’s largest prizes for academic research has been awarded to the Belgian bioinformatician Yves Moreau for his work in promoting ethical standards in the use of human...
Newly launched firm secures £4.3 million seed funding to target drug-resistant bacteria
November 19, 2023
Glox Therapeutics, a company developing precision antibiotic therapies, has raised £4.3 million in seed funding to develop effective targeted therapeutics against antibiotic-resistant bacteria.
Latest Digital Issue
